Sophia von Stockum

No ORCID on file · 7 papers in corpus · active 2020-2025

Study types

  • article 6
  • other 1

Condition tags

  • endometriosis 6
other 2025
BJOG: An International Journal of Obstetrics & Gynaecology ·doi:10.1111/1471-0528.17973

BACKGROUND: Endometriosis diagnosis reportedly faces delays of up to 10 years. Despite growing awareness and improved guidelines, information on the current status is limited. OBJECTIVES: To systematically assess the published evidence on …

article 2024
·doi:10.1097/aog.0000000000005509

This pooled analysis compared the risk of venous thromboembolism (VTE) associated with combined oral contraceptives (COCs) containing estradiol (E2) valerate-dienogest with those containing ethinyl E2-levonorgestrel. Data were retrieved fro…

article 2021
·doi:10.1177/2284026521993688

Introduction: The Visanne Post-approval Observational Study (VIPOS) was designed to assess the safety of dienogest 2 mg (DNG, Visanne) compared to other hormonal endometriosis treatments. Methods: Large, prospective, non-interventional, act…

article 2021
·doi:10.1177/22840265211035993

Introduction: Women with endometriosis require individualized, long-term treatment. Analyzing prescription choices, medication switches, discontinuations, and breaks can describe real-world treatment patterns and optimize pathways for women…

article 2021
·doi:10.1177/22840265211019546

Background: Several promising new medications containing low-dose estradiol (E2) in combination with a progestin and an additional component, such as gonadotropin-releasing hormone antagonists, are currently being developed for use in pre-m…

article 2020
Fertility and Sterility ·doi:10.1016/j.fertnstert.2020.08.241
article 2020
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2020.05.049